Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanorod-Aptamer Combo Targets Tumors

Abstract:
Aptamers, short stretches of DNA or RNA that can act much like antibodies, have shown promise as targeting agents for selective nanoparticle trafficking to tumors. Their ability to recognize and bind to tumor-specific molecules is undisputed, but the strength with which aptamers bind to their molecular targets is often insufficient to act as an effective targeting agent under clinically relevant conditions.

Nanorod-Aptamer Combo Targets Tumors

Bethesda , MD | Posted on January 16th, 2008

Now, a research team headed by Weihong Tan, Ph.D., at the University of Florida has shown that adding up to 80 aptamers on a single gold/silver nanorod increases the binding ability of this construct by at least 26-fold compared with that of an individual aptamer. Using dye-labeled aptamers, the investigators also were able to produce a cancer-detecting probe whose fluorescent signal is more than 300 times greater than that produced by individual dye-labeled aptamers. This work was published in the journal Analytical Chemistry.

In earlier work, Tan and his colleagues had shown that aptamer-labeled magnetic nanoparticles could be used to separate cancer cells from a mixture of normal and malignant cells. In the current study, he and his colleagues have extended the utility of aptamer targeting by demonstrating that multiple copies of an aptamer, when distributed along the surface of a nanorod, dramatically increase the binding affinity of the nanoscale construct through cooperative binding.

Cooperative binding works in much the same way as the multiple hooks and loops on Velcro®. If the interaction between one hook and loop, or one aptamer and its cellular target, is disrupted, other binding pairs maintain the connection between the two objects, whether it be the nanorod and cancerous cell or the two halves of a Velcro® pair. These findings, the investigators note, suggest that even aptamers that bind weakly, but specifically, to a cancer-related target could still prove useful as nanoparticle targeting agents. Indeed, the use of multiple weak-binding aptamers could reduce nonspecific binding of targeted nanoparticles or nanorods to healthy cells.

This work, which was supported in part by the NCI, is detailed in the paper "Cancer cell targeting using multiple aptamers conjugated on nanorods." An investigator from National Taiwan University in Taipei, Taiwan, also participated in this study. An abstract of this paper is available through PubMed.

####

About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © National Cancer Institute

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View abstract

Related News Press

News and information

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014

Graphene chips are close to significant commercialization October 1st, 2014

Nanomedicine

Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs October 1st, 2014

Nanobotmodels present metastasis and angiogenesis medical animation October 1st, 2014

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014

Discoveries

Breakthrough in ALD-graphene by Picosun technology October 1st, 2014

Novel approach to magnetic measurements atom-by-atom October 1st, 2014

Nanoparticles Accumulate Quickly in Wetland Sediment: Aquatic food chains might be harmed by molecules "piggybacking" on carbon nanoparticles October 1st, 2014

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

Announcements

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014

Graphene chips are close to significant commercialization October 1st, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE